Diana Lüftner

Comparison of Orally Administered Cannabis Extract and Delta-9-Tetrahydrocannabinol in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial From the Cannabis-In-Cachexia-Study-Group

Florian Strasser, Diana Lüftner, Kurt Possinger et al. · Journal of Clinical Oncology · 2006 · 402 citations · Full text

Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies

Francisco J. Esteva, Carol D Cheli, Herbert A. Fritsche et al. · Breast Cancer Research · 2005 · 152 citations · Full text

Serum HER‐2/<i>neu</i> and relative resistance to trastuzumab‐based therapy in patients with metastatic breast cancer

Suhail M. Ali, Walter P. Carney, Francisco J. Esteva et al. · Cancer · 2008 · 94 citations

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer

Achim Wöckel, Jasmin Festl, Tanja Stüber et al. · Geburtshilfe und Frauenheilkunde · 2018 · 93 citations · Full text

Primary analysis from DS8201-A-U105: A phase 1b, two-part, open-label study of trastuzumab deruxtecan (T-DXd) with nivolumab (nivo) in patients (pts) with HER2-expressing urothelial carcinoma (UC).

Matt D. Galsky, Gianluca Del Conte, Silvia Foti et al. · Journal of Clinical Oncology · 2022 · 85 citations

Immunology, Immunoediting, Pathology +17